Equities

XORTX Therapeutics Inc

XORTX Therapeutics Inc

Actions
Basic MaterialsIndustrial Metals and Mining
  • Price (USD)1.75
  • Today's Change-0.01 / -0.57%
  • Shares traded12.47k
  • 1 Year change-70.98%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Aug-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy1
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in CAD

The 2 analysts offering 12 month price targets for XORTX Therapeutics Inc have a median target of 12.18, with a high estimate of 14.04 and a low estimate of 10.32. The median estimate represents a 596.07% increase from the last price of 1.75.
High702.2%14.04
Med596.1%12.18
Low490.0%10.32

Earnings history & estimates in CAD

On Nov 14, 2023, XORTX Therapeutics Inc reported 3rd quarter 2023 losses of -0.899 per share.
Average growth rate-1.23%
XORTX Therapeutics Inc reported annual 2022 losses of -6.39 per share on Mar 31, 2023.
More ▼

Revenue history & estimates in CAD

-32768 did not report revenues for the 3rd quarter 2023. However, during the 3rd quarter of the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.